Your browser doesn't support javascript.
loading
The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.
Nechiporuk, Tamilla; Kurtz, Stephen E; Nikolova, Olga; Liu, Tingting; Jones, Courtney L; D'Alessandro, Angelo; Culp-Hill, Rachel; d'Almeida, Amanda; Joshi, Sunil K; Rosenberg, Mara; Tognon, Cristina E; Danilov, Alexey V; Druker, Brian J; Chang, Bill H; McWeeney, Shannon K; Tyner, Jeffrey W.
Afiliação
  • Nechiporuk T; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon.
  • Kurtz SE; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Nikolova O; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon.
  • Liu T; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Jones CL; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • D'Alessandro A; Department of Biomedical Engineering, Oregon Health and Science University, Portland, Oregon.
  • Culp-Hill R; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon.
  • d'Almeida A; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Joshi SK; Division of Hematology, University of Colorado Denver, Aurora, Colorado.
  • Rosenberg M; Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, Colorado.
  • Tognon CE; Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, Colorado.
  • Danilov AV; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon.
  • Druker BJ; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Chang BH; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon.
  • McWeeney SK; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Tyner JW; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon.
Cancer Discov ; 9(7): 910-925, 2019 07.
Article em En | MEDLINE | ID: mdl-31048320
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Mieloide Aguda / Proteína Supressora de Tumor p53 / Compostos Bicíclicos Heterocíclicos com Pontes / Proteínas Proto-Oncogênicas c-bcl-2 / Mitocôndrias Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Mieloide Aguda / Proteína Supressora de Tumor p53 / Compostos Bicíclicos Heterocíclicos com Pontes / Proteínas Proto-Oncogênicas c-bcl-2 / Mitocôndrias Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article